Evidence map›Paper›PMID 25826778›Full record

Observational studyUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology2015

Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis-fundus height.

M Griffin, P T Seed, L Webster, J Myers, L MacKillop, N Simpson, D Anumba, A Khalil, M Denbow, A Sau and 7 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Analysis of serum placental growth factor levels in preeclamptic and normotensive pregnant women in Lagos, Nigeria: a worthwhile screening tool?Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2022
    Article
  9. Toward personalized management of chronic hypertension in pregnancy.American journal of obstetrics and gynecology · 2022
    Review
  10. Article
  11. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2021
    Article
  12. Review
  13. Findings in Stillbirths Associated with Placental Disease.American journal of perinatology · 2020
    Article
  14. Comparison of three commercially available placental growth factor-based tests in women with suspected preterm pre-eclampsia: the COMPARE study.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2019
    Article
  15. Article
  16. Predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2018
    Observational
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

M GriffinWomen's Health Academic Centre, King's College London, London, UK.
P T SeedWomen's Health Academic Centre, King's College London, London, UK.
L WebsterWomen's Health Academic Centre, King's College London, London, UK.
J MyersMaternal and Fetal Health Research Centre, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
L MacKillopOxford University Hospitals NHS Trust, Oxford, UK.
N SimpsonSection of Obstetrics & Gynaecology, Institute of Biochemical & Clinical Sciences, University of Leeds, Leeds, UK.
D AnumbaAcademic Unit of Reproductive and Developmental Medicine, University of Sheffield, Sheffield, UK.
A KhalilSt George's Hospital Medical School, University of London, London, UK.
M DenbowSt Michael's Hospital, Bristol, UK.
A SauUniversity Hospital, Lewisham, London, UK.
K HinshawSunderland Royal Hospital, Sunderland, UK.
P von DadelszenDepartment of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.
S BentonDepartment of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.
J GirlingWest Middlesex University Hospital, Isleworth, Middlesex, UK.
C W G RedmanNuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, UK.
L C ChappellWomen's Health Academic Centre, King's College London, London, UK.
A H ShennanWomen's Health Academic Centre, King's College London, London, UK.

Funding

Department of Health NIHR-CS-011-020Department of Health RP-2014-05-019
6 · The paper itself

Abstract

objectivesTo assess the diagnostic accuracy of placental growth factor (PlGF) and ultrasound parameters to predict delivery of a small-for-gestational-age (SGA) infant in women presenting with reduced symphysis-fundus height (SFH).

methodsThis was a multicenter prospective observational study recruiting 601 women with a singleton pregnancy and reduced SFH between 24 and 37 weeks' gestation across 11 sites in the UK and Canada. Plasma PlGF concentration < 5(th) centile, estimated fetal weight (EFW) < 10(th) centile, umbilical artery Doppler pulsatility index > 95(th) centile and oligohydramnios (amniotic fluid index < 5 cm) were compared as predictors for a SGA infant < 3(rd) customized birth-weight centile and adverse perinatal outcome. Test performance statistics were calculated for all parameters in isolation and in combination.

resultsOf the 601 women recruited, 592 were analyzed. For predicting delivery of SGA < 3(rd) centile (n = 78), EFW < 10(th) centile had 58% sensitivity (95% CI, 46-69%) and 93% negative predictive value (NPV) (95% CI, 90-95%), PlGF had 37% sensitivity (95% CI, 27-49%) and 90% NPV (95% CI, 87-93%); in combination, PlGF and EFW < 10(th) centile had 69% sensitivity (95% CI, 55-81%) and 93% NPV (95% CI, 89-96%). The equivalent receiver-operating characteristics (ROC) curve areas were 0.79 (95% CI, 0.74-0.84) for EFW < 10(th) centile, 0.70 (95% CI, 0.63-0.77) for low PlGF and 0.82 (95% CI, 0.77-0.86) in combination.

conclusionsFor women presenting with reduced SFH, ultrasound parameters had modest test performance for predicting delivery of SGA < 3(rd) centile. PlGF performed no better than EFW < 10(th) centile in determining delivery of a SGA infant.

Indexed as

AdultAmniotic FluidFemaleFetal Growth RetardationHumansInfant, NewbornInfant, Small for Gestational AgeIntercellular Signaling Peptides and ProteinsPlacenta Growth FactorPredictive Value of TestsPregnancyPregnancy ProteinsPregnancy Trimester, ThirdPubic SymphysisReproducibility of ResultsROC CurveIntercellular Signaling Peptides and ProteinsPGF protein, humanPlacenta Growth FactorPregnancy Proteinsestimated fetal weightfetal growth restrictionplacental growth factorsmall-for-gestational age

Identifiers

PMID25826778
PMCPMC4744762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.